Buy Hyzaar Online

What is Hyzaar?

Hyzaar contains a combination of hydrochlorothiazide and losartan. Hydrochlorothiazide is a thiazide diuretic (water pill) that helps prevent your body from absorbing too much salt, which can cause fluid retention. Losartan is an angiotensin II receptor antagonist. Losartan keeps blood vessels from narrowing, which lowers blood pressure and improves blood flow.

Hyzaar is used to treat high blood pressure (hypertension). It is also used to lower the risk of stroke in certain people with heart disease.

Hyzaar may also be used for purposes not listed in this medication guide.

Important information about Hyzaar

Do not use Hyzaar if you are pregnant. Stop using and tell your doctor right away if you become pregnant.

You should not use Hyzaar if you are unable to urinate, or if you are allergic to penicillin or sulfa drugs.

If you have diabetes or kidney disease, you may not be able to take Hyzaar if you are taking medication that contains aliskiren. Tell your doctor about all medicines you use.

In rare cases, Hyzaar can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure. Call your doctor right away if you have unexplained muscle pain, tenderness, or weakness especially if you also have fever, unusual tiredness, and dark colored urine.

Before taking Hyzaar

You should not use Hyzaar if you are allergic to hydrochlorothiazide or losartan, if you are unable to urinate.

If you have diabetes or kidney disease, you may not be able to take this medicine if you are also taking a blood pressure medication that contains aliskiren (Amturnide, Tekturna, Tekamlo, or Valturna).

To make sure Hyzaar is safe for you, tell your doctor if you have:

  • kidney disease;

  • liver disease;

  • congestive heart failure;

  • glaucoma;

  • asthma;

  • low or high levels of potassium in your blood;

  • gout;

  • lupus;

  • diabetes; or

  • an allergy to sulfa drugs or penicillin.

FDA pregnancy category D. Do not use Hyzaar if you are pregnant. Stop using and tell your doctor right away if you become pregnant. Hyzaar can cause injury or death to the unborn baby if you take the medicine during your second or third trimester. Use effective birth control.

It is not known whether hydrochlorothiazide and losartan passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

How should I take Hyzaar?

Take Hyzaar exactly as prescribed by your doctor. Follow all directions on your prescription label. Your doctor may occasionally change your dose to make sure you get the best results. Do not take this medicine in larger or smaller amounts or for longer than recommended.

Take Hyzaar with a full glass (8 ounces) of water.

Your blood pressure will need to be checked often. Your kidney function may also need to be checked.

You may have very low blood pressure while taking this medication. Call your doctor if you are sick with vomiting or diarrhea, or if you are sweating more than usual.

If you need surgery, tell the surgeon ahead of time that you are using Hyzaar. You may need to stop using the medicine for a short time.

If you are being treated for high blood pressure, keep using this medication even if you feel well. High blood pressure often has no symptoms. You may need to use blood pressure medication for the rest of your life.

Store Hyzaar at room temperature away from moisture and heat.

What happens if I miss a dose?

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while taking Hyzaar?

This medication may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.

Drinking alcohol can further lower your blood pressure and may increase certain side effects of Hyzaar.

Avoid becoming overheated or dehydrated during exercise and in hot weather. Follow your doctor's instructions about the type and amount of liquids you should drink. In some cases, drinking too much liquid can be as unsafe as not drinking enough.

Do not use potassium supplements or salt substitutes while you are taking Hyzaar, unless your doctor has told you to.

Hyzaar side effects

Get emergency medical help if you have any of these signs of an allergic reaction to Hyzaar: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

In rare cases, Hyzaar can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure. Call your doctor right away if you have unexplained muscle pain, tenderness, or weakness especially if you also have fever, unusual tiredness, and dark colored urine.

Call your doctor at once if you have:

  • eye pain, vision problems;

  • a light-headed feeling, like you might pass out;

  • swelling, rapid weight gain, little or no urinating;

  • drowsiness, confusion, mood changes, increased thirst, loss of appetite, nausea and vomiting;

  • fast or pounding heartbeats;

  • pale skin, easy bruising or bleeding;

  • jaundice (yellowing of the skin or eyes); or

  • high potassium (slow heart rate, weak pulse, muscle weakness, tingly feeling).

Common Hyzaar side effects may include:

  • stomach pain;

  • back pain;

  • dizziness, tired feeling;

  • skin rash;

  • runny or stuffy nose, sore throat; or

  • dry cough.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Hyzaar?

Tell your doctor about all medicines you use, and those you start or stop using during your treatment with Hyzaar, especially:

  • any other blood pressure medications;

  • steroids (prednisone and others);

  • lithium;

  • cholestyramine or colestipol;

  • insulin or oral diabetes medication;

  • rifampin;

  • a barbiturate--phenobarbital and others;

  • any other diuretic or "water pill";

  • NSAIDs (non-steroidal anti-inflammatory drugs)--ibuprofen (Advil, Motrin), naproxen (Aleve), celecoxib, diclofenac, indomethacin, meloxicam, and others;

  • a muscle relaxer--baclofen, carisoprodol, cyclobenzaprine, methocarbamol, tizanidine, and others; or

  • narcotic medication--codeine, fentanyl, hydrocodone, hydromorphone, methadone, morphine, oxycodone, and others.

This list is not complete. Other drugs may interact with Hyzaar, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

For the Consumer

Applies to hydrochlorothiazide / losartan: oral tablet

Along with its needed effects, hydrochlorothiazide / losartan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking hydrochlorothiazide / losartan:

Symptoms of fluid and electrolyte imbalance
  • Dry mouth
  • increased thirst
  • muscle cramps or pain
  • nausea or vomiting
  • unusual tiredness or weakness
  • weak or irregular heartbeat
  • Black, tarry stools
  • blood in the urine or stools
  • cough or hoarseness accompanied by chills or fever, lower back or side pain, or painful or difficult urination
  • fainting
  • pinpoint red spots on the skin
  • pounding heartbeat
  • severe stomach pain, nausea, and vomiting
  • skin rash
  • swelling of the feet or lower legs
  • unusual bleeding or bruising
Incidence not known
  • Coma
  • confusion
  • convulsions
  • dark-colored urine
  • decreased urine output
  • fast or irregular heartbeat
  • fever
  • irritability
  • large, flat, blue, or purplish patches in the skin
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
  • light-colored stools
  • muscle spasms
  • muscle stiffness
  • muscle twitching
  • painful knees and ankles
  • raised red swellings on the skin, the buttocks, legs or ankles
  • restlessness
  • seizures
  • shortness of breath
  • swelling of the face, ankles, or hands
  • upper right abdominal or stomach pain
  • weakness
  • yellow eyes and skin

Some side effects of hydrochlorothiazide / losartan may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common
  • Cold or flu-like symptoms
  • dizziness
  • headache
  • increased sensitivity of the skin to sunlight
  • sore throat
  • stomach pain
  • Dry cough
  • sinus problems

Tags: avapro vs losartan, hyzaar, hyzaar 100 25 on line, buy cheap hydrochlorothiazide, where to buy hyzaar, purchase hyzaar over the counter, online pharmacy no prescription hyzaar, order hydrochlorothiazide, generic losartan, purchase losartan online, hyzaar online, buy hydrochlorothiazide, buy hydrochlorothiazide online, order losartan online, cheap hydrochlorothiazide, buy lisinopril / hydrochlorothiazide, cheap hyzaar, buy hyzaar, purchase hydrochlorothiazide online, no prescription hyzaar, hyzaar american express, order hyzaar, purchase losartan, buy hyzaar online, buy losartan, purchase hyzaar, buy losartan online, hyzaar without prescription, purchase hydrochlorothiazide, cheap losartan, hyzaar without prescriptionj, buy cheap losartan, purchasing hyzaar online, cozaar losartan, order losartan, order hydrochlorothiazide online, generic hydrochlorothiazide

Applies to hydrochlorothiazide / losartan: oral tablet


Hydrochlorothiazide-losartan is generally well-tolerated. The overall incidence of adverse experiences reported with losartan monotherapy appears to be similar to placebo. For the most part, side effects associated with the combination drug are transient and mild. In controlled clinical trials, discontinuation of therapy due to adverse drug events has been reported in 2.5% and 2.3% of patients treated with the combination and placebo, respectively.

General side effects reported postmarketing have included malaise thought to be related to the losartan component.


Since HCTZ may increase total serum cholesterol by 11%, LDL lipoprotein cholesterol by 12%, and VLDL lipoprotein cholesterol levels by 50%, and since it may reduce insulin secretion, it should be used with caution in patients with hypercholesterolemia and/or diabetes.

HCTZ-induced hyperuricemia may be an important consideration in patients with a history of gout. Hypophosphatemia and low serum magnesium concentrations may occur, but are usually clinically insignificant except in malnourished patients.

Metabolic side effects associated with HCTZ are more commonly associated with daily HCTZ doses of 50 mg or more, which are not recommended with the combination product. These side effects may occur at lower doses, however, and include mild hypokalemia (decrease of 0.5 mEq/L), metabolic alkalosis, hyponatremia, hypomagnesemia, hypercalcemia, hyperglycemia, hypercholesterolemia and elevated serum uric acid levels.


Hypersensitivity reactions typically present as nausea, vomiting, diarrhea, and rash, and are probably due to the HCTZ component. Hypersensitivity is reported in less than 1% of patients. Cases of acute pulmonary edema, interstitial cystitis or nephritis, and anaphylaxis have also been associated with HCTZ.


Cardiovascular side effects associated with losartan include dizziness in 5.7% (vs. 2.9% in placebo-treated subjects) and orthostatic hypotension. Rarely, HCTZ-induced hypokalemia or hyponatremia have been associated with significant cardiac arrhythmias including ventricular ectopy and complete AV heart block. Hypokalemia is much less likely with the combination drug, however, since losartan inhibits aldosterone secretion. Fingernail clubbing has also been associated with the use of losartan. In addition, angioneurotic edema has been reported during losartan therapy.

Nervous system

Nervous system side effects associated with losartan include headache in up to 14%, asthenia/fatigue in 4%, insomnia in 1% of patients, and rare cases of ageusia (altered tasted) and migraine headache. Rare cases of cerebrovascular insufficiency have been associated with HCTZ induced plasma volume contraction. Dysgeusia has been reported with losartan in postmarketing experience.


A 67-year-old white woman with hypothyroidism, hypercalcemia, depression, and hypertension developed facial erythema, headaches, tremors, confusion, and personality changes associated with a new positive ANA and anti-nRNP and a skin biopsy consistent with lupus erythematosus while taking HCTZ, levothyroxine, and amitriptyline. The eruption resolved upon discontinuation of HCTZ, but she later developed a higher ANA titer associated with symptomatic diffuse interstitial pulmonary infiltrates. She was successfully treated with corticosteroids.

Dermatologic reactions associated with HCTZ include erythema annular centrifugum, acute eczematous dermatitis, and morbilliform or leukocytoclastic vasculitis. Thiazides may induce phototoxic dermatitis. In addition, a rare, distinct entity with clinical and laboratory features indistinguishable from those of subacute cutaneous lupus erythematosus has been associated with HCTZ. Erythroderma has been reported with losartan in postmarketing experience.


The increase in plasma renin activity associated with losartan is relatively small compared with those increases associated with ACE inhibitors. These blunted increases do not appear to affect the antihypertensive response to the antagonist.

In one study of patients with significant proteinuria and moderate renal insufficiency (average creatinine clearance > 60 mL/min), losartan 50 to 100 mg/day was associated with significantly increased renal plasma flow and significantly decreased urinary excretion of total protein, albumin, and immunoglobulin.

Although HCTZ has been used to treat nephrogenic diabetes insipidus, a case in which the drug was believed to have caused this condition has been reported.

Renal side effects including new or worsened renal insufficiency may occur due to HCTZ-induced intravascular volume depletion. Rare cases of interstitial nephritis have been associated with HCTZ. Decreased renal function or hyperkalemia has only rarely been associated with losartan, although experience with this drug is limited compared with the related compounds, the ACE inhibitors. The effects of losartan and ACE inhibitors on renal hemodynamics and kidney function are similar. In addition, acute renal failure associated with losartan therapy has been reported in at least one patient with bilateral renal artery stenosis.


Thiazide diuretics may increase serum cholesterol and triglycerides, resulting in increased risk of cholesterol gallstone formation. Reports of bowel strictures associated with thiazide ingestion were reported in the 1960's, although these patients were on a combination HCTZ-potassium product.

Gastrointestinal complaints have been reported in less than 2% of patients, and have included loose bowel movements, dyspepsia, epigastric discomfort, and nausea. Rare cases of pancreatitis and acute cholecystitis have been associated with HCTZ. Dysgeusia, ageusia, and oral ulcers associated with losartan therapy have been rarely reported. Acute pancreatitis has also been associated with losartan use.


Respiratory system side effects are rare. Cough has been reported in 3.4% of treated patients and 3.3% of patients taking placebo. One comparative study has shown that losartan reduces coughing in patients who have a history of cough associated with ACE inhibitors. However, cases of cough, including rechallenge, have been associated with losartan use in postmarketing research. Nasal congestion has been reported in 1% to 2% of patients. Approximately 30 cases of acute noncardiogenic pulmonary edema have been associated with thiazide diuretics. These cases have been thought to be due to idiosyncrasy or a hypersensitivity mechanism.


Musculoskeletal side effects including back or leg pain have been reported in approximately 1% of patients, compared to 0% with placebo. In addition, rare reports of rhabdomyolysis have been reported during postmarketing experience in patients receiving angiotensin II receptor blockers.


Immunologic side effects are rare, and include cases of allergic vasculitis and hemolytic anemia associated with HCTZ. A case of Henoch-Schonlein purpura with a high titer of x-specific antineutrophil cytoplasmic antibodies (xANCA) has been associated with losartan therapy.


Hematologic side effects are rare. Cases of immune-complex hemolytic anemia, aplastic anemia, and thrombocytopenia have been associated with HCTZ. Hematologic side effects associated with losartan have included reports of small decreases in hemoglobin and hematocrit in which no patients were discontinued due to anemia. In addition, anemia has been reported in renal transplant recipients (not having posttransplant erythrocytosis) treated with losartan. Losartan has also been implicated in a case of immune thrombocytopenia. Thrombocytopenia has also been noted in postmarketing experience with losartan.


A prospective study of 34 patients who received oral thiazide diuretics for 14 years without interruption revealed an increased mean fasting blood glucose level after treatment. Withdrawal of thiazide therapy for 7 months in 10 of the patients resulted in mean reductions of 10% in the average fasting blood glucose value and 25% in the average 2-hour glucose tolerance test value. A control group was not reported.

Endocrinologic problems associated with thiazide diuretics include glucose intolerance and a potentially deleterious effect on the lipid profile. This may be important in some patients with or who are at risk for diabetes or coronary artery disease.


Hepatic side effects including increases in hepatic enzymes and serum bilirubin have been reported only occasionally with losartan. Less than 0.1% of patients from large-scale controlled trials discontinued losartan therapy due to increased liver function tests. Hepatitis has been reported rarely with losartan therapy.


Ocular side effects have included idiosyncratic reactions to the hydrochlorothiazide component resulting in acute transient myopia and acute angle-closure glaucoma.